0000950170-24-084295.txt : 20240717 0000950170-24-084295.hdr.sgml : 20240717 20240717163005 ACCESSION NUMBER: 0000950170-24-084295 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240715 FILED AS OF DATE: 20240717 DATE AS OF CHANGE: 20240717 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reich Samuel J CENTRAL INDEX KEY: 0001394645 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39871 FILM NUMBER: 241122565 MAIL ADDRESS: STREET 1: ACUITY PHARMACEUTICALS INC STREET 2: 3701 MARKET STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SAB Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001833214 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 853899721 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 W 41ST ST STREET 2: SUITE 401 CITY: MIAMI BEACH STATE: FL ZIP: 33140 BUSINESS PHONE: 305-845-2813 MAIL ADDRESS: STREET 1: 777 W 41ST ST STREET 2: SUITE 401 CITY: MIAMI BEACH STATE: FL ZIP: 33140 FORMER COMPANY: FORMER CONFORMED NAME: Big Cypress Acquisition Corp. DATE OF NAME CHANGE: 20201120 4 1 ownership.xml 4 X0508 4 2024-07-15 0001833214 SAB Biotherapeutics, Inc. SABS 0001394645 Reich Samuel J 777 W 41ST ST SUITE 401 MIAMI BEACH FL 33140 true true false false CEO & EXECUTIVE CHAIRMAN false Stock Option (right to buy) 2.9 2024-07-15 4 A false 35700 0 A 2034-07-15 Common Stock 35700 35700 D Represents a one-time grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest 25% on July 15, 2025, and in equal monthly installments thereafter over a three-year period ending July 15, 2028. This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended. /s/ Samuel J. Reich 2024-07-17